IP Library › Granted Patent US 12,496,252
Granted Patent B2
US 12,496,252 · App. 17/093,764 · Granted Dec 16, 2025

Adaptive high frequency chest wall oscillation system

Inventors: Aaron A. Ayu (Singapore, SG); Kok Boon R. Ong (Singapore, SG); Deny D. Barilea (Singapore, SG); John A. Bobey (Daniel Island, SC); Leonardo B. Artiaga, Jr. (Singapore, SG); Xiaolan Zhang (Singapore, SG); Wei Bian (Singapore, SG); Yong Guan Tay (Singapore, SG); Mo Chuk Wong (Singapore, SG); Qingqing Koh (Singapore, SG); Joo Cheng Chhua (Singapore, SG); Stacey Reuland (Crystal, MN); Mathieu Bernard (Pluvigner, FR)
Assignee: HILL-ROM SERVICES PTE. LTD.
A61H23/0254A61H2201/1619A61H2201/165A61H2201/5023A61H2201/5084A61H2205/084A61H2230/405
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,496,252
App. No.
17/093,764
Granted
Dec 16, 2025
Kind
B2
Abstract

Devices, systems, and methods for HFCWO oscillation therapy can enhance expectoration by preferred impact to the user to encourage mucus dislodging, including by successive pressure imposition to a chest engagement device to provide HFCWO.

Claims (33)

1 . A chest wall oscillation therapy system, comprising:

a chest engagement device for communicating impact force to a patient's chest;

a force generator arranged to generate successive force of impact as a therapy regime for the patient, the force generator arranged in communication with the chest engagement device to communicate force of impact from the force generator into impact force to the patient's chest to encourage airway clearance, and

a therapy control system comprising at least one sensor arranged to detect an indication of a breathing pattern of the patient, wherein the therapy control system is arranged to dynamically configure the therapy regime of the force generator according to data from the at least one sensor including, for each cycle of inhalation and exhalation of the patient, to decrease an oscillation rate of the impact force while the patient inhales, and then, in response to cessation of inhalation, to increase the oscillation rate of the impact force while the patient exhales, wherein active therapy of the therapy regime continues for at least a portion of time while the patient inhales to communicate impact force during inhalation, wherein the therapy control system configures the therapy force generator to have an inhalation setting for the oscillation rate during patient inhalation, the inhalation setting being less than an exhalation setting for the oscillation rate during patient exhalation such that the patient experiences lesser time of force of impact during patient inhalation than during patient exhalation.

2 . The chest wall oscillation therapy system of claim 1 , wherein the at least one sensor comprises at least one micro electromechanical sensors.

3 . The chest wall oscillation therapy system of claim 2 , wherein the at least one sensor is mounted to the chest engagement device to detect motion of the patient's chest.

4 . The chest wall oscillation therapy system of claim 1 , wherein the at least one sensor is arranged to provide at least nine-axis tracking of chest movement of the patient.

5 . The chest wall oscillation therapy system of claim 1 , wherein the at least one sensor comprises at least one accelerometer.

6 . The chest wall oscillation therapy system of claim 1 , wherein the at least one sensor comprises at least one gyroscope.

7 . The chest wall oscillation therapy system of claim 1 , wherein the at least one sensor comprises at least one magnetometer.

8 . The chest wall oscillation therapy system of claim 1 , wherein the therapy control system includes at least one processor for providing construction of motion based on data received from the at least one sensor.

9 . The chest wall oscillation therapy system of claim 1 , wherein the therapy control system is arranged in communication with a personal mobile device to communicate indication of the patient's chest.

10 . The chest wall oscillation therapy system of claim 1 , wherein the therapy control system includes a graphical user interface for communicating with a user.

11 . The chest wall oscillation therapy system of claim 10 , wherein the graphical user interface is arranged to present selectable options for user selection.

12 . The chest wall oscillation therapy system of claim 11 , wherein the selectable options for user selection include an oscillation start button for initiating operation to provide impact force to the patient.

13 . The chest wall oscillation therapy system of claim 12 , wherein responsive to user selection of the oscillation start button, the graphical user interface presents a pause button.

14 . The chest wall oscillation therapy system of claim 12 , wherein the selectable options for user selection include a new predetermined therapy regime button for user creation of a new predetermined therapy regime for implementation as the therapy regime.

15 . The chest wall oscillation therapy system of claim 14 , wherein the new predetermined therapy regime button is accessible by user activation of a pull tab for expansion.

16 . The chest wall oscillation therapy system of claim 12 , wherein the selectable options for user selection include an unlock button, wherein responsive to user selection of the unlock button at least one of frequency, intensity, and time buttons are presented as selectable options for user selection to configure corresponding features.

17 . The chest wall oscillation therapy system of claim 16 , wherein user activation of the unlock button includes dragging the unlock button to a predetermined extent.

18 . The chest wall oscillation therapy system of claim 17 , wherein the therapy control system includes a garment size toggle switch operable for user selection between an on position in which the therapy control system adapts configuration of the force generator to account for the size of the wearable garment, and an off position in which the therapy control system does not adapt configuration of the force generator to account for the size of the wearable garment.

19 . The chest wall oscillation therapy system of claim 12 , wherein the selectable options for user selection include a predetermined therapy regime tab for implementing a predetermined therapy regime as the therapy regime.

20 . The chest wall oscillation therapy system of claim 19 , wherein responsive to user selection of at least one of the predetermined therapy regime tab and an unlock button, a cough pause tab is presented for user selection to configure cough pause settings of the predetermined therapy regime.

21 . The chest wall oscillation therapy system of claim 20 , wherein responsive to user selection of the cough pause tab at least one of a cough pause enable switch and auto-restart switch is presented for user selection.

22 . The chest wall oscillation therapy system of claim 21 , wherein responsive to user selection of the cough pause enable switch to affirm cough pause, at least one of a pause duration and pause frequency button are presented for user selection to adjust corresponding features.

23 . The chest wall oscillation therapy system of claim 11 , the selectable options include a pull tab for user activation to present additional selectable options, wherein the additional selectable options include at least one of a home button, a cough pause settings button, and a delete therapy button.

24 . The chest wall oscillation therapy system of claim 1 , wherein the chest engagement device comprises a wearable garment.

25 . The chest wall oscillation therapy system of claim 1 , wherein the therapy control system configures the therapy force generator to have an exhalation setting for at least one of the oscillation rate and an intensity of the impact force during patient exhalation, the exhalation setting being greater than a predetermined nominal setting for the at least one of the oscillation frequency and the intensity of the impact force.

26 . The chest wall oscillation therapy system of claim 1 , wherein the therapy control system configures the therapy force generator to have an inhalation setting for the intensity of the impact force during patient inhalation, the inhalation setting being less than the exhalation setting during patient exhalation.

27 . The chest wall oscillation therapy system of claim 26 , wherein the inhalation setting is less than or equal to the predetermined nominal setting.

28 . The chest wall oscillation therapy system of claim 1 , wherein the therapy control system configures the therapy force generator to have an inhalation setting for at least one of the oscillation rate and an intensity of the impact force during patient inhalation, the inhalation setting being less than a predetermined nominal setting for the at least one of the oscillation frequency and the intensity of the impact force.

29 . The chest wall oscillation therapy system of claim 28 , wherein the therapy control system configures the therapy force generator to have an exhalation setting for at least one of the oscillation frequency and the intensity of the impact force during patient exhalation, the exhalation setting being greater than the inhalation setting during patient inhalation.

30 . The chest wall oscillation therapy system of claim 29 , wherein the exhalation setting is greater than or equal to the predetermined nominal setting.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2021
From: AYU, AARON A.; ONG, KOK BOON R.; BARILEA, DENY D.; BOBEY, JOHN A.; ARTIAGA, LEONARDO B., JR.; ZHANG, XIAOLAN; BIAN, WEI; TAY, YONG GUAN; WONG, MO CHUK; KOH, QINGQING; CHHUA, JOO CHENG; REULAND, STACEY; BERNARD, MATHIEU
To: HILL-ROM SERVICES PTE. LTD.
Reel/Frame 055123/0548 →
Continuity (2)
Provisional Application 62933920 · Nov 11, 2019
Related Publication 20210137779A1 · May 13, 2021
References Cited (159)
US 1833103A · Anderson · 1931 [cited by applicant]
US 2699163A · Carl-Gunnar · 1955 [cited by applicant]
US 2762366A · Huxley, III et al. · 1956 [cited by applicant]
US 2772673A · Huxley · 1956 [cited by applicant]
US 2779329A · Huxley, III et al. · 1957 [cited by applicant]
US 2780222A · Polzin et al. · 1957 [cited by applicant]
US 2832335A · Huxley et al. · 1958 [cited by applicant]
US 2845062A · Kling et al. · 1958 [cited by applicant]
US 3120228A · Huxley, III · 1964 [cited by applicant]
US 3333581A · Robinson et al. · 1967 [cited by applicant]
US 3548811A · Wilson · 1970 [cited by applicant]
US 3566862A · Schuh et al. · 1971 [cited by applicant]
US 3896794A · Mcgrath · 1975 [cited by applicant]
US 4003373A · Spelio · 1977 [cited by applicant]
US 4079733A · Denton et al. · 1978 [cited by applicant]
US 4398531A · Havstad · 1983 [cited by applicant]
US 4424806A · Newman et al. · 1984 [cited by applicant]
US 4637386A · Baum · 1987 [cited by applicant]
US 4838263A · Warwick · 1989 [cited by examiner]
US 4971042A · Lerman · 1990 [cited by applicant]
US 4977889A · Budd · 1990 [cited by applicant]
US 5056505A · Warwick et al. · 1991 [cited by applicant]
US 5137432A · Tsai · 1992 [cited by applicant]
US 5163818A · Betsill et al. · 1992 [cited by applicant]
US 5360323A · Hsieh · 1994 [cited by applicant]
US 5398676A · Press et al. · 1995 [cited by applicant]
US 5453081A · Hansen · 1995 [cited by applicant]
US 5508908A · Kazama et al. · 1996 [cited by applicant]
US 5529467A · Rometsch · 1996 [cited by applicant]
US 5551843A · Hauser · 1996 [cited by applicant]
US 5569170A · Hansen · 1996 [cited by applicant]
US 5682878A · Ogden · 1997 [cited by applicant]
US 5769797A · Van Brunt et al. · 1998 [cited by applicant]
US 5830164A · Cone et al. · 1998 [cited by applicant]
US 5848878A · Conti et al. · 1998 [cited by applicant]
US 5997488A · Gelfand et al. · 1999 [cited by applicant]
US 6030353A · Van Brunt · 2000 [cited by applicant]
US 6036662A · Van Brunt et al. · 2000 [cited by applicant]
US 6066101A · Johnson et al. · 2000 [cited by applicant]
US 6179793B1 · Rothman et al. · 2001 [cited by applicant]
US 6182656B1 · Sagiv · 2001 [cited by applicant]
US 6210345B1 · Van Brunt · 2001 [cited by applicant]
US 6254556B1 · Hansen et al. · 2001 [cited by applicant]
US 6290660B1 · Epps et al. · 2001 [cited by applicant]
US 6340025B1 · Van Brunt · 2002 [cited by applicant]
US D453560S · Van Brunt · 2002 [cited by applicant]
US 6361512B1 · Mackay et al. · 2002 [cited by applicant]
US 6379316B1 · Van Brunt et al. · 2002 [cited by applicant]
US 6390790B1 · Robertson et al. · 2002 [cited by applicant]
US 6415791B1 · Van Brunt · 2002 [cited by applicant]
US 6468237B1 · Lina · 2002 [cited by applicant]
US 6488641B2 · Hansen · 2002 [cited by applicant]
US 6544202B2 · McEwen et al. · 2003 [cited by applicant]
US 6547749B2 · Hansen · 2003 [cited by applicant]
US 6558338B1 · Wasserman · 2003 [cited by applicant]
US 6605050B2 · Hansen · 2003 [cited by applicant]
US 6676614B1 · Hansen et al. · 2004 [cited by applicant]
US 6708690B1 · Hete et al. · 2004 [cited by applicant]
US D504945S · Van Brunt et al. · 2005 [cited by applicant]
US 6958046B2 · Warwick et al. · 2005 [cited by applicant]
US 7115104B2 · Van Brunt et al. · 2006 [cited by applicant]
US 7121808B2 · Van Brunt et al. · 2006 [cited by applicant]
US D531728S · Helgeson · 2006 [cited by applicant]
US 7207953B1 · Goicaj · 2007 [cited by examiner]
US D547718S · Helgeson et al. · 2007 [cited by applicant]
US 7278978B1 · Hansen et al. · 2007 [cited by applicant]
US 7316658B2 · Gagne · 2008 [cited by applicant]
US 7374550B2 · Hansen et al. · 2008 [cited by applicant]
US 7425203B2 · Van Brunt et al. · 2008 [cited by applicant]
US D585991S · Helgeson et al. · 2009 [cited by applicant]
US 7491182B2 · Van Brunt · 2009 [cited by applicant]
US 7537575B2 · Hansen et al. · 2009 [cited by applicant]
US 7582065B2 · Van Brunt et al. · 2009 [cited by applicant]
US 7615017B2 · Van Brunt et al. · 2009 [cited by applicant]
US 7713219B2 · Helgeson et al. · 2010 [cited by applicant]
US 7736324B1 · Helgeson · 2010 [cited by applicant]
US 7762967B2 · Warwick et al. · 2010 [cited by applicant]
US 7770479B2 · Hansen et al. · 2010 [cited by applicant]
US D639954S · Helgeson et al. · 2011 [cited by applicant]
US 8038633B2 · Van Brunt et al. · 2011 [cited by applicant]
US 8052626B2 · Huster · 2011 [cited by examiner]
US 8087316B2 · Holtgraver · 2012 [cited by applicant]
US 8192381B2 · Nozzarella · 2012 [cited by applicant]
US 8197428B2 · Helgeson et al. · 2012 [cited by applicant]
US 8202237B2 · Helgeson et al. · 2012 [cited by applicant]
US 8257287B2 · Hanlon et al. · 2012 [cited by applicant]
US 8257288B2 · Hansen et al. · 2012 [cited by applicant]
US 8353207B2 · Hakansson · 2013 [cited by applicant]
US 8460223B2 · Huster · 2013 [cited by examiner]
US 8708937B2 · Van Brunt et al. · 2014 [cited by applicant]
US 8740824B2 · Hansen et al. · 2014 [cited by applicant]
US 8845562B2 · Receveur et al. · 2014 [cited by applicant]
US 8936447B2 · Abal · 2015 [cited by applicant]
US D742013S · Helgeson et al. · 2015 [cited by applicant]
US 9222818B2 · Hakansson et al. · 2015 [cited by applicant]
US 9289350B2 · Helgeson et al. · 2016 [cited by applicant]
US 9316249B2 · Yoshizawa et al. · 2016 [cited by applicant]
US 9372662B2 · Hakansson et al. · 2016 [cited by applicant]
US 9901510B2 · Smith · 2018 [cited by applicant]
US 9968511B2 · Huster et al. · 2018 [cited by applicant]
US 10016335B2 · Hansen et al. · 2018 [cited by applicant]
US 10518048B2 · Bobey et al. · 2019 [cited by applicant]
US 10524975B2 · Clapp et al. · 2020 [cited by applicant]
US 20010007928A1 · Hansen · 2001 [cited by applicant]
US 20010027791A1 · Wallace et al. · 2001 [cited by applicant]
US 20020016560A1 · Hansen · 2002 [cited by applicant]
US 20020042938A1 · Hansen · 2002 [cited by applicant]
US 20020111571A1 · Warwick · 2002 [cited by examiner]
US 20040097849A1 · Van Brunt · 2004 [cited by examiner]
US 20050172965A1 · Thulin · 2005 [cited by applicant]
US 20050234372A1 · Hansen et al. · 2005 [cited by applicant]
US 20050235988A1 · Hansen et al. · 2005 [cited by applicant]
US 20060036199A1 · Warwick et al. · 2006 [cited by applicant]
US 20060101581A1 · Blanchard · 2006 [cited by examiner]
US 20070004992A1 · Van Brunt et al. · 2007 [cited by applicant]
US 20070093731A1 · Warwick et al. · 2007 [cited by applicant]
US 20070203433A1 · Murphy · 2007 [cited by examiner]
US 20080086062A1 · Hansen · 2008 [cited by examiner]
US 20080092884A1 · Hansen et al. · 2008 [cited by applicant]
US 20080108921A1 · Helgeson et al. · 2008 [cited by applicant]
US 20080294075A1 · Nozzarella · 2008 [cited by applicant]
US 20090093740A1 · Helgeson et al. · 2009 [cited by applicant]
US 20090234256A1 · Helgeson et al. · 2009 [cited by applicant]
US 20090306556A1 · Hansen et al. · 2009 [cited by applicant]
US 20100016770A1 · Van Brunt et al. · 2010 [cited by applicant]
US 20120022414A1 · Receveur · 2012 [cited by examiner]
US 20130118175A1 · Eisenmenger et al. · 2013 [cited by applicant]
US 20130261518A1 · Hansen et al. · 2013 [cited by applicant]
US 20130289455A1 · Clapp et al. · 2013 [cited by applicant]
US 20130331747A1 · Helgeson et al. · 2013 [cited by applicant]
US 20140276271A1 · Stryker · 2014 [cited by examiner]
US 20140290659A1 · Chen et al. · 2014 [cited by applicant]
US 20160151232A1 · Clapp et al. · 2016 [cited by applicant]
US 20160184174A1 · Hansen et al. · 2016 [cited by applicant]
US 20170007494A1 · Rock et al. · 2017 [cited by applicant]
US 20170281460A1 · Zgoda et al. · 2017 [cited by applicant]
US 20190133873A1 · Chase · 2019 [cited by examiner]
US 20190142686A1 · Lee · 2019 [cited by examiner]
US 20190274919A1 · Lee · 2019 [cited by examiner]
US 20210283008A1 · Shockley, Jr. · 2021 [cited by examiner]
US 20220354736A1 · Chen · 2022 [cited by examiner]
DE 4433068A1 · 1996 [cited by applicant]
DE 19726281A1 · 1998 [cited by applicant]
FR 342256A · 1904 [cited by applicant]
KR 20130037636A · 2013 [cited by examiner]
SE 143165C1 · 1953 [cited by applicant]
WO 0124698A1 · 2001 [cited by applicant]
WO 0206673A1 · 2002 [cited by applicant]
WO 2015171078A1 · 2015 [cited by applicant]
WO WO2017081352A1 · 2017 [cited by examiner]
WO WO2021214769A1 · 2021 [cited by examiner]
Japanese Office Action issued in Japanese Patent Application No. 2022-526807, drafted Apr. 14, 2023, and its English translation (8 pages). [cited by applicant]
Partial Supplementary European Search Report for European Patent Application No. 20887273.9, dated Dec. 12, 2022 (13 pages). [cited by applicant]
Examination Report No. 2 issued by the Australian Patent Office on Sep. 26, 2023 for Australian Patent Application No. 2020382453; 3 pages. [cited by applicant]
Office Action issued in Japanese Patent Application No. 2022-526807 on Aug. 18, 2023, and its English translation (7 pages). [cited by applicant]
Decision of Refusal issued in Japanese Patent Application No. 2022-526807 dated Feb. 16, 2024, and its English translation (5 pages). [cited by applicant]
Examination Report No. 3 issued by the Australian Patent Office on Dec. 22, 2023; 3 pages. [cited by applicant]
Chinese Office Action issued by the Chinese Patent Office on Jan. 23, 2025, for Chinese Patent Application No. 202080078335.9 and its English translation (14 pages). [cited by applicant]
Chinese Office Action issued by the Chinese Patent Office on Aug. 6, 2025, for Chinese Patent Application No. 202080078335.9 and its English translation (11 pages). [cited by applicant]